Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Rodman & Renshaw analyst Brandon Folkes initiated coverage on Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) with a Buy rating and announced a price target of $8. Adial Pharmaceuticals shares closed at $0.9910 on Wednesday. See how other analysts view this stock.
- Truist Securities analyst Keith Hughes initiated coverage on Carlisle Companies Incorporated (NYSE:CSL) with a Hold rating and announced a price target of $460. Carlisle shares closed at $454.83 on Wednesday. See how other analysts view this stock.
- Rodman & Renshaw analyst Brandon Folkes initiated coverage on Achieve Life Sciences, Inc (NASDAQ:ACHV) with a Buy rating and announced a price target of $12. Achieve Life Sciences shares closed at $4.53 on Wednesday. See how other analysts view this stock.
- Oppenheimer analyst Ian Zaffino initiated coverage on Turning Point Brands, Inc. (NYSE:TPB) with an Outperform rating and announced a price target of $65. Turning Point Brands shares closed at $55.00 on Wednesday. See how other analysts view this stock.
- Rodman & Renshaw analyst Brandon Folkes initiated coverage on Rockwell Medical, Inc. (NASDAQ:RMTI) with a Buy rating and announced a price target of $5. Rockwell Medical shares closed at $2.63 on Wednesday. See how other analysts view this stock.
Considering buying TPB stock? Here's what analysts think:
Read More:
- US Stocks Settle Mixed Following Inflation Data: Investor Sentiment Improves, But Fear Index Remains In 'Greed' Zone
